MARKET

BLFS

BLFS

BioLife
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.42
+1.51
+8.43%
After Hours: 19.42 0 0.00% 16:00 07/10 EDT
OPEN
18.55
PREV CLOSE
17.91
HIGH
19.98
LOW
17.88
VOLUME
726.83K
TURNOVER
--
52 WEEK HIGH
21.18
52 WEEK LOW
7.37
MARKET CAP
605.08M
P/E (TTM)
28.46
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BLFS stock price target is 22.38 with a high estimate of 26.00 and a low estimate of 17.00.

EPS

BLFS News

More
BioLife Solutions Announces Closing of $86 Million Public Offering of Common Stock
PR Newswire · 3d ago
Moving Average Crossover Alert: BioLife Solutions
Zacks · 4d ago
BioLife (BLFS) Catches Eye: Stock Jumps 12.1%
Zacks · 4d ago
66 Biggest Movers From Thursday
Gainers GEE Group, Inc. (NYSE: JOB) shares climbed 199.9% to close at $1.54 on Thursday after the company eliminated over $47 million in debt and mezzanine financing.
Benzinga · 4d ago
Here's Why BioLife Solutions Jumped Higher Today
Motley Fool · 07/02 19:48
The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1)
Benzinga · 07/02 12:21
BioLife Solutions Prices 5.175M Share Offering of Common Stock at $14.50/Share
Benzinga · 07/02 11:44
Edited Transcript of BLFS.OQ earnings conference call or presentation 14-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 07/02 00:04

Industry

Medical Equipment, Supplies & Distribution
-0.14%
Healthcare Equipment & Supplies
-0.35%

Hot Stocks

Symbol
Price
%Change

About BLFS

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.
More

Webull offers kinds of BioLife Solutions Inc stock information, including NASDAQ:BLFS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLFS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BLFS stock methods without spending real money on the virtual paper trading platform.